Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups.
Oosterveld M, Wittebol SH, Lemmens WA, Kiemeney BA, Catik A, Muus P, Schattenberg AV, de Witte TJ. Oosterveld M, et al. Among authors: lemmens wa. Br J Haematol. 2003 Oct;123(1):81-9. doi: 10.1046/j.1365-2141.2003.04544.x. Br J Haematol. 2003. PMID: 14510946
An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol.
Jongen PJ, Heerings M, Ruimschotel R, Hussaarts A, Evers S, Duyverman L, Valkenburg-Vissers J, Cornelissen J, Bos M, van Droffelaar M, Lemmens WA, Donders R, van der Zande A, Visser LH. Jongen PJ, et al. Among authors: lemmens wa. BMC Neurol. 2016 May 28;16:81. doi: 10.1186/s12883-016-0593-4. BMC Neurol. 2016. PMID: 27234001 Free PMC article. Clinical Trial.
S100B protein, glia and Gilles de la Tourette syndrome.
van Passel R, Schlooz WA, Lamers KJ, Lemmens WA, Rotteveel JJ. van Passel R, et al. Among authors: lemmens wa. Eur J Paediatr Neurol. 2001;5(1):15-9. doi: 10.1053/ejpn.2001.0399. Eur J Paediatr Neurol. 2001. PMID: 11277359
64 results